First Page | Document Content | |
---|---|---|
![]() Date: 2012-01-12 08:07:38Microbicides Microbiology HIV/AIDS Female reproductive system Vaginal microbicide HIV Pre-exposure prophylaxis AIDS Birth control Medicine Health Sexually transmitted diseases and infections | Source URL: www.oxha.orgDownload Document from Source WebsiteFile Size: 48,85 KBShare Document on Facebook |
![]() | October 26, 2007 Starpharma Pty Ltd Baker Building 75 Commercial Road Melbourne VIC 3004 AUSTRALIADocID: 1fIqv - View Document |
![]() | A TRAVEL LING E XH I B IT Featuring In Her Mother’s Shoes, a story and photo essay by The Seattle Times It is our hope that thisDocID: 1fzPE - View Document |
![]() | What is CAPRISA 004? CAPRISA 004 was a phase IIb, two-arm, double-blind, randomised, placebo-controlled trial designed to assess the safety and effectiveness of the vaginal microbicide candidate 1% tenofovir gel for theDocID: 1bY73 - View Document |
![]() | Global Campaign for Microbicides, www.global-campaign.org 5. What to Do About Male Partners? SDocID: 1aCH6 - View Document |
![]() | Microbicides Research & DevelopmentDocID: 1ayCz - View Document |